PROX1 and colorectal carcinoma: The methodologies included immunoblotting, real-time quantitative polymerase chain reaction (RT-qPCR), immunohistochemical (IHC) staining, and various functional assays, to assess the role of PROX1 together with α-SMA expression within CRC cell lines and patient tissues.